News
Patient advocate Barbara Moss joins Inspire2Live's international fight to make cancer drugs available to people in poorer countries like Africa ...
Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...
Three-dimensional (3D) cancer models have emerged as pivotal tools in oncology research, offering a more accurate representation of tumor biology compared ...
Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can ...
Researchers discovered how to flip the structure of complex drug compounds using a simple reagent, offering a game-changing ...
4d
Zacks Investment Research on MSNAstraZeneca Boasts Strong Oncology Portfolio: Can It Sustain Growth?AstraZeneca AZN is one of the leading drugmakers in the oncology space. Oncology sales (comprising around 41% of ...
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.
People are going on social media to share their belief that this antiparasitic drug can fight cancer. Learn what the science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results